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Objective. Ultrasonographic characteristics are associated with thyroid malignancy. Our aim was to compare the diagnostic value
of ultrasound features in the detection of thyroid malignancy in both solid and mixed nodules. Methods. We prospectively
studied female patients (≥50 years) referred to ultrasound-guided fine needle aspiration biopsy (2008–2012). Ultrasound features
considered suspicious were hypoechogenicity, microcalcifications, irregular margins, high anteroposterior (AP)/axial-ratio, and
absent halo. Associations were separately assessed in mixed and solid nodules. Results. In a group of 504 elderly female patients
(age = 69±8 years), the frequency ofmalignant cytology was 6%.Thirty-one percent of nodules weremixed and 60%were solid.The
rate of malignant cytology was similar for mixed and solid nodules (7.4 versus 5.8%, P: 0.56). While in mixed nodules none of the
ultrasound characteristics were associated withmalignant cytology, in solid nodules irregularmargins andmicrocalcifications were
significant (all 𝑃 < 0.05). The combination of irregular margins and/or microcalcifications significantly increased the association
with malignant cytology only in solid nodules (OR: 2.76 (95% CI: 1.25–6.10), P: 0.012). Conclusions. Ultrasound features were less
efficient in detecting malignancy in mixed nodules, which harbored malignant lesions as often as solid nodules in this population.
Our findings challenge the recommended minimal size for ultrasound-guided fine needle aspiration biopsy in mixed nodules.
1. Introduction
1
Thyroid nodules are among the most frequent disorders
referred to endocrinological practice. While 4–7% of the
general adult population has palpable thyroid nodules, more
than 50% has thyroid nodules on ultrasonography (US) [1].
Furthermore, an increasing incidence of thyroid cancer has2
been reported worldwide, and a possible explanation is the
more frequent practice of imaging studies. Regarding gender,
thyroid nodules, as well as thyroid cancer, are more common
in women than in men [2, 3]. In fact, out of 5234 subjects 3
aged >60 years in Framingham, clinically apparent thyroid
nodules were present in 6.4% of women and 1.5% of men
[2]. Furthermore, ageing is also associated with an increased 4
prevalence of nodular goiter. Moreover, it has been shown
that while nodular goiter is present in 2.7 and 2.0% of young
women andmen, respectively, themeanprevalence inwomen
and men over 55 years is 18.0 and 14.5%, respectively [4].
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More importantly, thyroid cancer in elderly patients portends
a more aggressive behavior [5] and mortality rates are higher
in patients over 45 years old at diagnosis [6]. Considering
that life expectancy has increased, diagnostic procedures in
the aged population should improve the detection of thyroid
cancer and help to avoid unnecessary surgical procedures.
US is the most common diagnostic tool used before
fine needle aspiration biopsy (FNAB) in thyroid nodular
disease. Certain US features, such as solid echostructure,
hypoechogenicity, irregular margins, absence of halo, micro-
calcifications, anteroposterior (AP) diameter larger than
axial diameter (taller than wider shape), and intranodular
vascularization, have all been proposed to help select nodules
that have to be biopsied [7, 8].However, the diagnostic impact
of these US features has not been fully explored in the elderly
population.
Mixed nodules represent 15–54% of all surgically excised
thyroid nodules [9–12] and although the proportion ofmalig-
nancy amongmixed nodules has been reported to be between
2% and 18% [12], in general, their relevance is minimized
because they are believed to represent a degenerative process
arising from benign lesions. In fact, the American thyroid
association (ATA) Guidelines [8] state that while all solid
nodules larger than 1 cm should undergo FNAB, mixed
cystic-solid nodules should be biopsied only when size is
larger than 1.5 or 2.0 cm in the presence of suspicious US
findings, or when size is above 2.0 cm if no suspicious US
findings are present.
Few studies analyzed US features associated with thyroid
cancer taking into consideration age, gender, and in particu-
lar the distinction betweenmixed and solid nodules. Our aim
was to compare the diagnostic value of US features for the
detection of thyroid malignancy in solid and mixed nodules
in an elderly female population.
2. Materials and Methods
2.1. Study Cohort and Protocol. Our study was performed
at the Dr. Cesar Milstein Hospital, which receives all the
patients belonging to the National Institute of Social Ser-
vices for Retirees and Pensioners (INSSJP), referred for US-
guided FNAB in the city of Buenos Aires. The population
selected for this study consisted of 504 female patients (age
= 69 ± 8 years) referred to the Dr. Cesar Milstein Hospital
between June 2008 and May 2012 for FNAB. All patients live
in Buenos Aires, which is considered an iodine-rich region
in Argentina. The main reasons for referral were a neck
mass that was visible and/or palpable or that had been found
incidentally in a previous CT or US. The study was approved
by the ethical committee of our institution and all patients
signed an informed consent form. Clinical and US details
were prospectively collected in a special form that was filled
out right before FNABwas performed.TheUS characteristics
of the nodules were described by the operator to a technician
whowas in charge of writing down the information provided.
2.2. Image Analysis. US characteristics were assessed by real-
timeUS in each thyroid nodule biopsied.These included type
of echostructure, echogenic pattern (the nodule echogenicity
was compared to normal thyroid and strap muscles), shape
of margins, presence of halo (complete or partial) and
microcalcifications, and the 3 diameters of the nodule in
mm.Microcalcificationswere defined as tiny, punctate hyper-
echoic foci, without comet-tail artifacts that may represent
precipitated colloid material. Coarse calcifications were not
considered for the analysis. In Table 1 are depicted the US
characteristics and each of their possible variants that were
described in each nodule.
Mixed or partially cystic nodules were defined by the
presence of an anechoic component. If a nodule had at
least 25% of anechoic component it was considered mixed.
Completely anechoic nodules were excluded from the study.
US features in mixed nodules were evaluated based on their
solid component.
2.3. US-Guided Fine Needle Aspiration Procedure. A Min-
dray DC-3 (Shenzhen, China) Doppler-echo machine and a
7.5–10MHz linear-array probe were used to guide all FNABs
in real time. Biopsies were performed using a 23-gauge
needle, and visualization of the tip of the needle inside the
nodule helped to monitor the correct site for biopsy. To
select the nodule for biopsy, we followed the ATA guidelines
[8]. US-guided FNABs were carried out by one of the three
operators of our institution, each having more than 15 years
of experience with this procedure. In some patients in whom
it was difficult to place the probe due to the shape of the neck,
the skin-marking technique was employed to perform FNAB
[13]. At least 2–6 needle passages were performed in each
nodule. Material obtained from FNABs was smeared on glass
slides, which were immediately placed in 95% alcohol for
Papanicolau staining and sent to the Pathology Department.
2.4. Cytological Analysis. Cytological analysis was performed
independently by two pathologists. Validation of this pro-
cedure by cytohistological correlation in our institution was
previously reported [13]. In the present series, 46 subjects
were referred to surgery and cancer was confirmed in 20 of
them (43%). After excluding indeterminate cases, cytology
showed a significant concordance with histological results
(kappa coefficient = 0.68, P < 0.001). For this study we
started recruiting patients before the Bethesda system was
introduced in our hospital practice. Therefore, we continued
using our former classification. Accordingly, results were
classified as benign, insufficient, indeterminate, and malig-
nant [13]. Results suspicious of papillary thyroid cancer
were included in the malignant category. However, those
suspicious of follicular/Hurthle cell neoplasm were included
in the indeterminate category together with results consistent
with atypical cells of undetermined significance.
2.5. Statistical Analysis. For statistical analysis, one nodule
was considered per patient. In patients who had two nodules
biopsied, with both showing benign cytology, the nodule
with the largest longitudinal diameter was considered for
analysis. In no case did both nodules biopsied show malig-
nant cytology. For statistical analysis, malignant cytology was
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Table 1: Ultrasonographic features evaluated in each thyroid nodule.
Echostructure Solid Mixed Cystic Spongiform
Echogenic pattern Hypoechoic Hyperechoic Isoechoic Anechoic
Margins Regular Irregular
Halo Presence Absence
Microcalcifications Presence Absence
Diameters (mm) Longitudinal Anteroposterior (AP) Axial
Table 2: General characteristics of mixed and solid nodules.
Mixed nodules
(𝑛 = 158)
Solid nodules
(𝑛 = 304)
𝑃 value
Patients’ age (years) 69 ± 7 69 ± 7 0.504
Longitudinal diameter
(mm, 𝑛 = 158/304) 21 (15–30) 17 (14–24) <0.001
Anteroposterior diameter
(mm, 𝑛 = 147/281) 14 (10–20) 11 (9–16) <0.001
Axial diameter
(mm, 𝑛 = 143/252) 16 (12–23) 13 (10–19) <0.001
Hypoechoicity
(%, 𝑛 = 148/298) 53 54 0.950
Irregular margins
(%, 𝑛 = 129/258) 40 37 0.604
Microcalcifications
(%, 𝑛 = 133/269) 42 39 0.554
Absence of halo
(%, 𝑛 = 102/214) 54 58 0.451
Taller than wider
(%, 𝑛 = 140/252) 29 39 0.057
Malignant cytology
(%, 𝑛 = 136/256) 7.4 5.8 0.565
The values in brackets indicate the number of patients with available
information for that specific variable. For continuous variables, results are
expressed as mean ± SD and median (interquartile range) corresponding to
Gaussian and non-Gaussian distribution, respectively.
considered as the gold standard. US features were considered
as dichotomous variables defined by the presence or absence
of the US characteristics. Taller than wider shape was defined
as a value of AP/axial diameters > 1. When comparing
the prevalence of the different echographic characteristics
between mixed and solid nodules, the Chi-square test was
employed. After discarding indeterminate and insufficient
cytology results, a subpopulation of 391 nodules with benign
and malignant cytological results was obtained. The associ-
ations among the different US characteristics and malignant
cytology were analyzed with the Chi-square test. Likelihood
ratios (LR) and posttest probabilities were calculated from
2 × 2 tables [14]. Pretest probability was defined as 0.06
(estimated from the whole sample). Data distribution was
assessed by the Shapiro-Wilks test. Continuous variables were
compared using the Student’s t-test or Mann-Whitney U test
according to data distribution. Multiple logistic regression
analysis was employed to find the combination of US char-
acteristics best associated with the presence of malignant
cytology. Normally distributed variables are presented as
mean ± S.D. and skewed variables as median (interquartile
range). A P value < 0.05 was considered significant. All
analyses were performed with SPSS 17.0 statistical software
(IBM, Chicago, IL, USA).
3. Results
Attesting to the elderly female population included (𝑛 =
504), the age distribution of the patients was 6%: 50–60
years; 53%: 60–70 years; 34%: 70–80 years; and 7%: >
80 years (mean age = 69 ± 8 years). Among the overall
population of nodules, the following cytological results were
obtained: 6% insufficient, 8% indeterminate, 80%benign, and
6% malignant. Cytological results were similar across age
intervals (data not shown).
According to their echostructure, nodules were classified
as mixed (31%), solid (60%), cystic (2%), and spongiform
(1%), while in 6% of cases echostructure data was missing.
The prevalence of other suspicious US features among all
nodules was hypoechoicity (54%), irregular margins (38%),
microcalcifications (39%), absence of halo (31%), and taller
than wider shape (36%). Subsequently, only mixed and solid
nodules were analyzed (n = 462). General characteristics of
these 2 groups are depicted in Table 2. Mixed nodules pre-
sented larger diameters, in accordance with the indications
stated in the ATA guidelines for FNAB [8]. Taller than wider
shape was the only echographic feature in which a lower
prevalence was observed inmixed nodules, though this result
was not statistically significant. Noteworthy, there was no
difference in the prevalence of malignant cytology between
mixed and solid nodules. Moreover, the number of cases in
which cancer (80% papillary carcinoma) was confirmed by
histology was similar for both types of nodules (5.7 versus
3.7%, P = 0.85).
The associations between US features and malignant
cytology in mixed and solid nodules are shown in Table 2.
Strikingly, for mixed nodules, none of the US characteristics
analyzed were significantly associated with malignant cytol-
ogy (Table 2). Nonetheless, the positive LR was significantly
increased for mixed nodules with no halo. By contrast,
in solid nodules, irregular margins and microcalcifications
were significantly associated with malignant cytology and
increased the positive LR.
Despite the lack of significant association with malignant
cytology, it is worth noting that US features that improved the
posttest probability for malignant cytology in mixed nodules
were absence of halo and taller than wider shape. By contrast,
in solid nodules, irregular margins and microcalcifications
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Table 3: Associations between US features with malignant cytology in both mixed and solid nodules.
Echo structure US feature PrevalenceBenign (%)
Prevalence
Malignant (%)
∗𝑃 value Sensitivity Specificity LR (CI95) Posttestprobability (%)
Mixed nodules
(𝑛 = 135)
Hypoechoic
(𝑛 = 125;𝑀: 9) 50 56 0.767 0.56 0.50
1.10
(0.60–2.03) NI
Irregular margins
(𝑛 = 111;𝑀: 6) 36 33 0.887 0.33 0.64
0.92
(0.29–2.94) NI
Microcalcifications
(𝑛 = 113;𝑀: 8) 42 50 0.655 0.50 0.58
1.2
(0.57–2.47) NI
Absence of halo
(𝑛 = 86;𝑀: 6) 49 83 0.102 0.83 0.51
1.71
(1.12–2.61) 9.8
Taller than wider
(𝑛 = 135;𝑀: 6) 26 50 0.209 0.50 0.74
1.88
(0.80–4.44) 10.7
Solid nodules
(𝑛 = 256)
Hypoechoic
(𝑛 = 250;𝑀: 15) 53 50 0.805 0.50 0.47
0.94
(0.88–0.97) NI
Irregular margins
(𝑛 = 218;𝑀: 11) 36 73 0.015 0.73 0.63
2.00
(1.37–2.93) 11.3
Microcalcifications
(𝑛 = 225;𝑀: 13) 39 69 0.029 0.69 0.61
1.79
(1.20–2.67) 10.3
Absence of halo
(𝑛 = 181;𝑀: 9) 60 55 0.769 0.55 0.40
0.92
(0.51–1.67) NI
Taller than wider
(𝑛 = 209;𝑀: 8) 40 62 0.211 0.62 0.60
1.55
(0.88–2.72) 9.0
Indeterminate cytology nodules were discarded prior to the analysis. The values in brackets indicate the number of patients with available information for that
specific variable and the total cases of malignant cytology. Pretest probability in this population was 0.06. NI: not improved compared to pretest probability.
∗
𝑃 value corresponds to that obtained in the Chi-square test.
Table 4: Association of the combination between the presence of microcalcifications and/or irregular margins and the presence of malignant
cytology.
Echostructure Model Wald OR 95% CI 𝑃 value
Mixed
(𝑛 = 118;𝑀: 9)
Age 0.512 0.967 0.881–1.061 0.474
Irregular margins-microcalcifications 0.077 1.128 0.484–2.626 0.781
Solid
(𝑛 = 207;𝑀: 15)
Age 1.710 0.940 0.857–1.031 0.191
Irregular margins-microcalcifications 6.275 2.759 1.247–6.103 0.012
The values in brackets indicate the number of patients with available information for that specific variable and the total cases of malignant cytology included.
were characteristics that significantly improved the posttest
probability of malignant cytology (Table 3). Interestingly,
taller than wider shape slightly improved the posttest prob-
ability in both types of nodules. Although mixed nodules
were larger than solid ones, among malignant nodules there
was no difference in any of the three measured diameters
(longitudinal: 2.0 (1.7–2.7) versus 1.8 (1.3–2.4) cm; AP: 2.0
(1.0–2.1) versus 1.7 (0.9–2.0) cm; and axial: 2.0 (1.0–3.0) versus
1.2 (0.9–1.7) cm, all P > 0.05 for mixed and solid nodules,
resp.).
Given thatmicrocalcifications and irregularmarginswere
the 2 parameters best associated with malignant cytology in
solid nodules, we ran amultiple logistic regression analysis to
evaluate if a combination of both US features was associated
with malignant cytology. For mixed nodules, neither age
nor the compound between irregular margins and micro-
calcifications was significantly associated with malignant
cytology. As for solid nodules, the presence of irregular
margins/microcalcifications was statistically significant, thus
showing that the odds for malignant cytology gradually
increase 2.7-fold if a nodule presents one or both US features
(Table 4). 5
4. Discussion
The most important finding of this study was the identifica-
tion of different profiles of US characteristics associated with
malignant cytology, exhibited by mixed and solid thyroid
nodules. For mixed nodules, the association of absence of
halo and malignant cytology showed a trend, while for solid
nodules the association of irregularmargins andmicrocalcifi-
cations with malignant cytology proved significant. Overall,
these results suggest that in an aged population (94% > 60
years), US characteristics performquite acceptably to identify
suspicious solid nodules. However, this is not true for mixed
nodules, in which US suspicious characteristics were not
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efficient to guide FNAB. Further concerns are raised by the
facts that (a) malignancy was found to a similar extent in
mixed and solid nodules and (b) similar diameters were
observed in malignant mixed and solid thyroid nodules.
Based on these findings, mixed nodules should be biopsied
at the same size thresholds as solid nodules, as opposed to
what the current ATA guidelines suggest.
US is a helpful tool in the detection of thyroid cancer,
and several scores have been recently proposed to select
the nodule which should be biopsied [15, 16]. Papini et
al. reported that the combination of solid echostructure
with hypoechogenic pattern has 87% sensitivity for thyroid
cancer, albeit with low specificity and low positive predic-
tive value [17]. In addition, microcalcifications have also
been extensively studied and described as one of the main
predictors of papillary thyroid cancer [18]. Consistent with
these findings, in the present study microcalcifications were
significantly associated with malignant cytology, but only for
solid nodules. Irregularmargins are anotherUS featurewhich
has proved to be highly specific for thyroid malignancy [17].
In fact, in solid nodules we observed that irregular margins
were associated with malignant cytology, above any other US
feature. A possible explanation for such observation is that
elderly patients might have had thyroid cancer long enough
to enable the occurrence of local invasion.
As to the taller than wider shape, this feature exhibited
high specificity for malignancy in both mixed and solid
nodules.The shape of the “taller thanwider” nodule, although
not extensively described, has been previously mentioned
in the literature where, in agreement with our work, it was
found to be specific but with reduced sensitivity [19]. In breast
cancer, this concept of AP growth is widely accepted [20]
but is less than that for the thyroid. US reports of thyroid
nodules often describe only one diameter, in particular, the
longitudinal diameter and lack information regarding the
AP or axial diameters. This neglected information could
be, however, very helpful to understand tumor growth.
Malignant tumors have a centrifugal growth pattern while
benign nodules tend to expand in the longitudinal axis of the
thyroid lobe, in parallel with the skin [19].
Few studies have specifically addressed US features in
mixed thyroid nodules [21]. In contrast with our results, Sohn
et al. [22] described that US features in mixed nodules were
significant predictors of thyroid cancer. In their study, the rate
of malignancy was 4% in a series of 316 mixed nodules, 32%
of which presented with suspicious US features, while only
2.7% did not. Their findings led to the suggestion that mixed
nodules without suspicious US features could be followed
by US even if they grew in size. However, among the 316
mixed nodules, the proportion of nodules with suspicious US
features was really low, only 6%. Additionally, in some US-
based classifications to detect malignancy in mixed nodules,
some of the US features considered are different from those
generally described [21, 23]. These include eccentric configu-
ration with an acute angle, macrolobulated or irregular free
margin of the solid component, centripetal vascularity in
the pedicle, and associated cervical lymphadenopathy with
intranodal cystic components or microcalcifications [21, 24,
25]. Based on these features, Kim et al. [26] have proposed a
US-based classification system to differentiate benign from
malignant in partially cystic thyroid nodules. They proved
the diagnostic accuracy of US for thyroid nodules to be very
high in a large series of 1289 nodules, among which 234 were
partially cystic. However, in line with our results, they used
different classification criteria for solid andmixed nodules. In
this context, the use of a specific classification only for mixed
nodules is highly recommended. Future studies regarding the
accuracy of US features to guide FNAB in mixed thyroid
nodules are warranted.
Another consideration is that it would be expected that
as nodules exhibit more US suspicious features, the odds of
presenting malignant cytology should markedly increase. In
fact, Kwak et al. [27] showed that the risk of malignancy
increased in parallel with the number of suspicious US
features. However, in the present study this was only true for
solid nodules in which irregular margins and/or microcalci-
fications increased the odds for malignant cytology 2.7-fold.
Further studies are needed in order to reach consensus about
the US characteristics that should be considered for FNAB.
Although most of the previous studies reported the
sensitivity and specificity of different US characteristics to
detect malignant nodules, calculation of the LR and posttest
probability highlights some clinical aspects of our results. In
this regard, though sensitivity and specificity are crucial to
describe the performance of a test, their interpretation in
clinical practice is not as simple as positive LR and posttest
probabilities. The LR has an advantage over sensitivity and
specificity because it is less likely to change with the preva-
lence of the disorder. Furthermore, the posttest probability
shows how the presence of a certain US feature improves the
chance to find malignant cytology in a particular nodule.
We acknowledge our limitation regarding cytological
instead of pathological criteria for malignancy. However,
this was decided given the high cytopathological correla-
tion found in our Institution. Also, information regarding
vascularity was not included in the analyses due to a high
prevalence ofmissing data.The selection of a populationwell-
defined by sex and age (94% > 60 years) represents a clear
strength, since most studies were carried out in both male
and female populations encompassing a wide age range (21–
80 years).
In conclusion, US features were less efficient in detecting
malignancy in mixed nodules, which harbored malignant
lesions as often as solid nodules in this population. Based
on our findings, we believe that different criteria should be
considered for US-guided FNAB in mixed nodules, and the
recommended minimal size for US-guided FNAB should be
unified for mixed and solid nodules.
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